Overview

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

Status:
Terminated

Trial end date:
2011-11-01

Target enrollment:

Participant gender:

Summary

In the treatment of patients with candidemia and/or other forms of invasive candidiasis , Anidulafungin is at least as effective and safe as Fluconazole.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Anidulafungin
Echinocandins
Fluconazole